CLINICAL_TRIALS
trial_result
· 2022-04-14
Clinical Trial Update: Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma [Phase 2]
Summary
Phase 2 trial assessing safety and efficacy of avelumab in small intestinal adenocarcinoma has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2022-04-14